Knight Cancer Institute

Fingerprint Dive into the research topics where Knight Cancer Institute is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.

    • Network Recent external collaboration on country level. Dive into details by clicking on the dots.

    Profiles

    No photo of Anupriya Agarwal

    Anupriya Agarwal

    Person: Academic

    20082020
    No photo of Eric Anderson

    Eric Anderson

    Person: Academic

    20052018
    No photo of Grover Bagby

    Grover Bagby

    Person

    1966 …2017

    Projects

    OHSU Center for Specialized Data Analysis as part of the GDAN

    Spellman, P.

    National Institutes of Health

    9/13/16 → 8/31/21

    Project: Research project

    • Oregon Emergency Care Research Multidisciplinary Training Program

    Newgard, C. & Morris, C.

    National Institutes of Health

    8/15/16 → 6/30/21

    Project: Research project

    • Integrative approach to heterogeneity in breast cancer metastasis

    Spellman, P.

    National Institutes of Health

    6/1/16 → 5/31/21

    Project: Research project

    • Research Output

    AACR calls on congress to take immediate action against COVID-19 and protect patients with cancer during the pandemic

    Mardis, E. R., Ribas, A., Hait, W. N., Jaffee, E. M., Foti, M., Abate-Shen, C., Albini, A., Bernards, R., Cruz-Correa, M. R., Flaherty, K. T., Greenberg, P. D., June, C. H., Knudsen, K. E., Liu, E. T., Mills, G. B., Piccart, M. J., Roussel, M. F., Siu, L. L., Swanton, C. & Tuveson, D. A., Jun 2020, In : Cancer discovery. 10, 6, p. 771-774 4 p.

    Research output: Contribution to journal › Article

    Open Access

    • A case study of 10 patients administered HBOC-201 in high doses over a prolonged period: outcomes during severe anemia when transfusion is not an option

    Zumberg, M., Gorlin, J., Griffiths, E. A., Schwartz, G., Fletcher, B. S., Walsh, K., Dao, K. H., Vansandt, A., Lynn, M. & Shander, A., May 1 2020, In : Transfusion. 60, 5, p. 932-939 8 p.

    Research output: Contribution to journal › Article

    • A first-in-human phase 1 dose escalation study of spartalizumab (PDR001), an anti-PD-1 antibody, in patients with advanced solid tumors

    Naing, A., Gainor, J. F., Gelderblom, H., Forde, P. M., Butler, M. O., Lin, C. C., Sharma, S., Ochoa De Olza, M., Varga, A., Taylor, M., Schellens, J. H. M., Wu, H., Sun, H., Silva, A. P., Faris, J., Mataraza, J., Cameron, S. & Bauer, T. M., Mar 15 2020, In : Journal for immunotherapy of cancer. 8, 1, e000530.

    Research output: Contribution to journal › Article

    Open Access
    • 5 Scopus citations